Vireo Health International, Inc. (OTC: VREO) began its first day as a publicly traded company on the Canadian Stock Exchange (CSE). The company, which is touted as one of America’s science-focused multi-state leaders, listed onto the CSE under the stock symbol of “VREO”.
The company previously announced that it would trade publically after it successfully raised over $50 million from a brokered and non-brokered private placement.
Kyle Kingsley, M.D., Chief Executive Officer of Vireo Health, stated: "Today is a historic milestone for Vireo Health. Our business and product offerings are expanding rapidly, and we expect the proceeds from our RTO transaction will enable us to significantly expand our geographic footprint and our investments in intellectual property development. We are proud of our track record of creating value for shareholders over time, and our board of directors and executive management team will continue to prioritize this important goal as we transition to operating as a public company.”
Dr. Kingsley added, "Vireo has been pursuing a business model consistent with this vision since its inception, and our leadership team is committed to achieving this objective.” He went on to stress that he has focused on the accessibility of their company’s e-commerce website and home delivery platforms to meet the demands of tech-savvy consumers.
A new website that was launched by the company today, accessible at the URL investors.vireohealth.com, offers Vireo Health investors with an easy way to access core information about the company.
About Viero Health:
"Vireo Health: Patient-focused, physician-led.
At Vireo Health, we believe medical marijuana is a great resource for treating a variety of qualifying conditions safely. By speaking with our patients about their diagnoses and their medical care, we’ll work together with the patient and their physician to craft a treatment plan that keeps the patient front and center. When you visit our New York medical marijuana dispensary, you’ll find compassionate physicians and pharmacists who are up-to-date on cannabis-based remedies and who understand the differences between the various capsules, oral solutions, vaporization cartridges, and vaporization oils we prescribe. Together, you’ll be able to decide which product may be right for you as we work to manage your condition.
Our best-in-class cannabis-based products are truly made with our patients in mind. As an integrated medical marijuana dispensary, we handle everything from seed to sale. Our knowledgeable staff of horticulturalists and scientists nurture our plants and create our products, while our compassionate physicians and pharmacists assist patients in our dispensaries.
Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We'll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.